Notebook
October 13th, 2007 by Richard Brassaw

At one point, immunoglobulin G (IgG) was studied as a potential therapy for Alzheimer’s disease and the results were not what researchers had hoped to achieve. Michael Steinitz, from Hebrew University in Jerusalem, focused on  immunoglobulin M (IgM) as a treatment for Alzheimer’s disease, but the problem with IgM is that scientists did not believe [...]

October 12th, 2007 by Richard Brassaw

This past July, the Federal Drug Administration (FDA) approved the first artificial neck disc. The traditional treatment for cervical degenerative disc disease (DDD) is to remove the diseased disc in a patient’s neck and then fuse two or more bony vertebrae. Degenerative disc disease is a normal part of aging and occurs when our intervertebral [...]

October 11th, 2007 by Richard Brassaw

In the October issue of Archives of Neurology, a physician who treats Parkinson Disease (PD) reports that a few of his patients have begun sleepwalking. For the past 2 years, Dr Rositsa Poryazova has treated 165 PD patients. Adult-onset of sleepwalking was identified in 6 of those patients. There were an equal number of men and [...]

October 10th, 2007 by Richard Brassaw

Chronic pain often leads to significant changes in a person’s daily routine. It is difficult to bend or stand for long periods of time because of the pain. Sleep is difficult and even taking a bath or shower can become a challenge. Pain medications are often the first form of treatment, but often the side effects make [...]

October 9th, 2007 by Richard Brassaw

Emerging evidence has shown that selective serotonin reuptake inhibitors (SSRIs) used in conjunction with non-steroidal anti-inflammatory drugs (NSAIDs) can cause bleeding of the lining of the digestive tract including the esophagus, stomach, or upper part of the small intestine–together called the upper gastrointestinal (GI). Researchers pooled data from 4 studies involving 153,000 patients. Patients taking [...]

October 8th, 2007 by Richard Brassaw

The Mayo Clinic thinks ‘refueling through relaxation’ needs to be near the top of your to-do list. As far as the Mayo Clinic is concerned, relaxation is a vital process that decreases wear and tear on the mind and body. Relaxation can reduce the heart rate, lower blood pressure, increase blood flow to major muscles, reduce [...]

October 7th, 2007 by Richard Brassaw

As the costs of health care continues to soar, consumers are looking for ways save money. As blockbuster drugs lose their patient protection, they are being manufactured by the major generic companies like: Teva Pharmaceutical, Barr Pharmaceuticals, Mylan Laboratories, Watson Pharmaceuticals, and Novartis. In an effort to increase the number of generic drugs available to [...]

October 6th, 2007 by Richard Brassaw

An estimated 2.1 million Americans are afflicted with rheumatoid arthritis (RA), a chronic and debilitating inflammatory disease of the joints. American and Swedish researchers used blood samples of rheumatoid arthritis patients, along with blood samples from healthy patients, to compare DNA in search of small differences in the genetic code. Independently, both groups were led [...]

October 5th, 2007 by Richard Brassaw

The Holy Grail of chronic pain is to eliminate the pain without impairing thinking, alertness, coordination, or other vital functions of the nervous system. A study using a combination of capsaicin—the substance that makes chili peppers hot—and a drug called QX-314, was successful in blocking pain-sensing neurons in rats without impairing movement or other sensations [...]

October 4th, 2007 by Richard Brassaw

Researchers at Northwestern University have made an interesting connection between Alzheimer’s disease and diabetes. They suggest that it is a 3rd form of diabetes. Type 3 diabetes affects the ‘amyloid Beta-derived diffusible ligand‘ (ADDL). ADDLs are small, soluble aggregated proteins that appear to accumulate during the early stages of Alzheimer’s disease and are known to block memory and learning [...]